Catalyst Biosciences, Inc. (CBIO): Stock Offering News

CBIO – Prices an underwritten public offering of 2,941,176 shares of its common stock at $34.00/share.


Key Facts Surrounding This News Item


  • CBIO had a POWR Rating of A (Strong Buy) coming into today.
  • CBIO was 31.30% above its 10-Day Moving Average coming into today.
  • CBIO was 47.72% above its 20-Day Moving Average coming into today.
  • CBIO was 115.99% above its 50-Day Moving Average coming into today.
  • CBIO was 228.98% above its 100-Day Moving Average coming into today.
  • CBIO was 377.11% above its 200-Day Moving Average coming into today.
  • CBIO had returned +161.00% year-to-date leading up to today’s news, versus a -0.57% return from the benchmark S&P 500 during the same period.

More Info About Catalyst Biosciences, Inc. (CBIO)


Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. The company is based in South San Francisco, California. View our full CBIO ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

CBIO at a Glance

CBIO Current POWR Rating™
Overall POWR Rating™
CBIO Current Price $10.14 0.80%
More CBIO Ratings, Data, and News

CBIO Price Reaction

The day of this event (Feb. 13, 2018)
CBIO Closing Price$34.36 3.48%
CBIO Volume1,686,400
233.30% from avg
Leading up to this event
CBIO 1-mo returnN/A%
After this event
CBIO 1-day return5.26%
CBIO 3-day return14.54%
CBIO 5-day return29.27%

CBIO Price Chart



More Catalyst Biosciences, Inc. (CBIO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CBIO News
Page generated in 1.2273 seconds.